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Introduction
The indiscriminate use of antimicrobial agents has resulted in 
the emergence of a number of drug-resistant bacteria, fungi, 
and viruses. To overcome the increasing resistance of patho-
genic microbes, more effective antimicrobial agents with novel 
modes of action must be developed. Medicinal plants used in 
traditional medicines to treat infectious diseases seem to be 
an abundant source of new bioactive secondary metabolites. 
Therefore, in the last few years, a variety of medicinal plants 
and plant extracts have been screened for their antimicrobial 
activity [1, 2]. Essential oils, derived from aromatic medicinal 
plants (e.g. fennel (Foeniculum vulgare), peppermint (Mentha 
piperita), thyme (Thymus vulgaris)), have been reported to be 
active against Gram-positive and Gram-negative bacteria as 
well as against yeasts, fungi, and viruses. They are mixtures of 
different lipophilic and volatile substances, such as monoter-
penes, sesquiterpenes, and/or phenylpropanoids, and have a 
pleasant odor. Furthermore, they are considered to be part of 
the preformed defense system of higher plants [3].
Whilst it is beyond the scope of the present survey to re-
view this expanding scientific field extensively, its progress 
will be documented by the most important results published 
in the last decade.
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Summary
The abundant use of anti-infective agents resulted in 
the emergence of drug-resistant bacteria, fungi, and vi-
ruses. To overcome the increasing resistance of patho-
genic microbes, a variety of medicinal plants have been 
screened worldwide for their antimicrobial properties. 
The aim is to find new, effective antimicrobial agents 
with novel modes of actions. Essential oils derived from 
aromatic medicinal plants have been reported to exhibit 
exceptionally good antimicrobial effects against bacteria, 
yeasts, filamentous fungi, and viruses. The progress of 
this expanding scientific field will be documented by the 
most important results published in the last decade.
Schlüsselwörter
Ätherische Öle · Arzneipflanzen · Antimikrobielle Aktivität · 
Zytotoxische Eigenschaften
Zusammenfassung
Der übermäßige Gebrauch von Antiinfektiva führte zum 
Auftreten von resistenten Bakterien, Pilzen und Viren. 
Um die vermehrte Resistenz von Mikroben zu überwin-
den, sind weltweit verschiedene Arzneipflanzen auf ihre 
antimikrobiellen Eigenschaften untersucht worden. Das 
Ziel ist es, neue, wirksame Antiinfektiva mit neuartigen 
Wirkmechanismen zu finden. Ätherische Öle bestimm-
ter Arzneipflanzen sind dafür bekannt, dass sie eine be-
sonders gute Wirkung gegen Bakterien, Pilze und Viren 
aufweisen. Der Fortschritt auf diesem wachsenden For-
schungsgebiet soll durch die wichtigsten Ergebnisse, die 
im letzten Jahrzehnt publiziert worden sind, dokumen-
tiert werden. 
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Medicinal Plants with Antibacterial and Antifungal 
 Essential Oils
During the last decade, a variety of essential oils have been 
screened to assess their antimicrobial activity (table 1). The 
antimicrobial activity of plant-derived essential oils formed 
the basis of many applications, especially in food preserva-
tion, aromatherapy, and complementary medicine. 
Essential Oils with Anti-Helicobacter Activity
Helicobacter pylori is a Gram-negative bacterium that colo-
nizes the epithelial surface of gastric mucosa. Nowadays, 
there is no doubt that H. pylori is a major etiological agent of 
acute and chronic gastritis. The role of the bacterium in the 
pathogenesis of peptic ulcer as well as in the development of 
adenocarcinoma of the distal stomach has been well-estab-
lished. To cure a H. pylori infection, a combined treatment of 
proton pump inhibitor with two antibiotics has shown to be 
successful. Since antibiotic resistance has developed, it is also 
necessary to find new agents against this type of bacterium 
as alternatives to existent antibiotics or as adjuvant agents in 
combination with established and still effective antibiotics.
Recently, isolated plant substances (e.g. alkaloids, flavo-
noids, polysaccharides) as well as plant extracts have been 
shown to be effective against H. pylori. In the last decade, 
several research groups have investigated essential oils from 
different plant origin for their anti-Helicobacter activity using 
a broth microdilution/macrodilution method (table 2). 
All essential oils tested exhibited a high anti-Helicobacter 
activity in vitro with MIC/MBC values of 20.0–589.4 µg/ml. Of 
all essential oils tested, carrot (Daucus carota) seed oil was the 
Table 1. A selection of aromatic plants with antimicrobial active essential oils
Origin of essential oil Bacteria Gram (+) Bacteria Gram (–) Yeasts, y Fungi, f MIC, μg/ml References
Allium sativum y f 64.0  [4]
Artemisia douglasiana + − y 156–625  [5]
Commiphora mukul + − 0.31–5% of oil  [6]
Cryptomeria japonica y f EC50: 39–110  [7]
Foeniculum vulgare + − 0.25–2.0% of oil  [8]
Juniperus communis + − 1.0–2.0% of oil  [8]
Lavandula angustifolia y 0.69–1.8% of oil  [9]
Melaleuca alternifolia y 0.03–0.125 [10]
Mentha arvensis + – f 400–800 [11]
Mentha spicata + − 400–800 [11]
Nigella sativa + y f 2500 [12]
Peumus boldus + − y 0.9–58.0 [13]
Pimpinella anisum y f 0.78–1.56% of oil [14]
Salvia sclarea f EC50: 493–584 µl/l [15]
Tagetes patula y f 1.25–10.0 µl/ml [16]
Thymbra capitata y f 0.08–0.32 µl/ml [17]
Thymus pulegioides y f 0.16–0.64 µl/ml [18]
Ziziphora clinopodioides + − 3,750 [19]
MIC = Minimum inhibitory concentration; Gram(+) = Gram-positive; Gram(–) = Gram-negative; EC50 = effective concentration of the test compound 
which inhibit the growth of fungus by 50%.
Table 2. Essential oils with antibacterial activity against Helicobacter 
pylori (values in italics indicate MBC values)
Origin of essential oil MIC/MBC, µg/ml References
Daucus carota  20.0 [20]
Cinnamomum zeylanicum  40.0 [20]
Satureja montana  40.0 [20]
Matricaria recutita  35.7–70.4 [21]
Nepeta argolica  64.0 [22]
Citrus aurantium  65.1 [21]
Mentha spicata  50.0–100.0 [11]
Zingiber officinale  65.4–130.9 [21]
Eugenia caryophyllus 100.0 [20]
Mentha arvensis 100.0 [11]
Nepeta camphorata 128.0 [22]
Melissa officinalis 135.7 [21]
Mentha piperita 135.7 [21]
Salvia officinalis 137.6 [21]
Rosmarinus officinalis 137.0 [21]
Leptospermum scoparium 140.0 [21]
Elettaria cardamomum 130.0–278.0 [21]
Thymus vulgaris 275.2 [21]
Coriandrum sativum 259.3 [21]
Foeniculum vulgare 288.3 [21]
Carum carvi 273.1 [21]
Ocimum basilicum 286.7–573.4 [21]
Illicium verum 294.7–589.4 [21]
Melaleuca alternifolia 539.0 [21]
MIC = Minimum inhibitory concentration; MBC = minimum bactericidal 
concentration.
most active one with an MBC value of 20.0 µg/ml. Moreover, 
recent studies reported the in vivo (e.g. mice and rats) efficien-
cy of different essential oils against antibiotic-susceptible and 
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-resistant H. pylori strains. It was also of interest that the bac-
tericidal activities of the essential oils tested were enhanced 
at acidic pH values [20, 23, 24]. Some scientists speculate that 
the anti-Helicobacter activities of several essential oils are rel-
evant if one intends to use them as food supplement to com-
plement standard therapy [20].
Tea Tree (Melaleuca alternifolia) Oil (TTO) with Anti- 
Mycoplasma pneumoniae Activity
Mycoplasmas are bacteria without a rigid cell wall. Their 
physiological habitats are plants and animals but in various 
circumstances they may become pathogenic for humans, too. 
Mycoplasma pneumoniae is spread all over the world. It fre-
quently causes atypical courses of pneumonia, particularly in 
children between 5 and 15 years and adults between 30 and 
35 years. As a result of lung inflammations, myocarditis, ar-
thritis, polyneuritis, and other chronic diseases may appear. 
Tetracyclines and macrolides are the preferred antibiotics in 
the treatment of mycoplasmal infections. However, in recent 
years bacterial strains emerged with a resistance to macrolide 
antibiotics.
The most common morphological shape of M. pneumoniae 
is the typical ‘pear shape’ with a tip structure at one end of the 
cell. There are specific protein filaments inside the tip struc-
ture which form the cytoskeleton [25]. When M. pneumoniae 
was treated with 0.006% TTO in ethanol (1%) for 12 h, the 
cells lost their typical ‘pear-shaped’ appearance and became 
rounded. The rounded shape resembles mutants which have 
lost their virulence as a result of this morphological change 
and the loss of their attachment site. TTO seems to affect the 
intracellular cytoskeletal structure in a way that M. pneumo-
niae cells become rounded and lose their virulence. On the 
other hand, the integrity of the cell membrane was not im-
paired by TTO [25].
In a recent in vitro experiment, Furneri et al. [26] exposed 
25 clinically isolated strains from vagina, urethra, cervix, 1 
reference strain of Mycoplasma hominis, 1 clinically isolated 
strain, 1 reference strain of M. pneumoniae, 4 clinically iso-
lated strains (from vagina), and 2 reference strains of Myco-
plasma fermentans to TTO. The MIC values were determined 
by a broth microdilution assay (table 3).
All Mycoplama species tested revealed, independently of 
their origin, a high susceptibility against TTO in vitro.
Antibacterial Activity against Bacteria from the Respiratory 
Tract
Essential oils are traditionally used for the treatment of respira-
tory tract infections due to their secretolytic and secretomotoric 
properties. Therefore, essential oils are either inhaled by steam, 
applied by inunction to the chest, or administered orally.
Bacterial respiratory tract infections develop in many cases 
from viral infections as common colds and include tonsillitis, 
sinusitis, bronchitis, and pneumonia. The bacteria most fre-
quently isolated from the respiratory tract are Streptococcus 
pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, 
and Streptococcus pyogenes. Therefore, it is of interest to focus 
Table 3. Susceptibility of different Mycoplasma species against tea 
tree (Melaleuca alternifolia) oil
Bacteria MIC, %
Mycoplasma hominis (26 isolates) 0.06–0.12
Mycoplasma fermentans (6 isolates) 0.01–0.06
Mycoplasma pneumoniae (2 isolates) 0.01
Origin of essential oil S. pneumoniae S. pyogenes H. influenzae M. catarrhalis References
Thymus vulgaris   800   200   200 − [27, 28]
    3.13*     6.25*     3.13* −
 6250 12500 12500 − [29]
Cinnamomum verum   400   200   200 − [27, 28]
    3.13*     6.25*     3.13* − [27, 28]
 6250  6250  6250 − [29]
Melissa officinalis   139   557   278 139 [30, 31]
Nepeta cataria   332  1329   664 332 
Cymbopogon citratus   800   400   800 − [27, 28]
    6.25*     6.25*     1.56* − [27, 28]
Mentha piperita  3200  1600   800 − [27, 28]
   25*    25*    12.5* − [27, 28]
Melaleuca alternifolia  3200  3200  1600 − [27, 28]
   25*    50*    50* − [27, 28]
Eucalyptus radiata  3200 >3200   − − [27, 28]
   25*    50*   50* − [27, 28]
Syzygium aromaticum 12500 12500 12500 − [29]
*MIC-values in gaseous phase.
Table 4. Anti-
microbial activity 
of various essential 
oils against bacteria 
of the respiratory 
tract (MIC values in 
µg/ml)
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on the susceptibility of these bacteria to essential oils. Table 4 
gives an overview on the MIC values of different oils tested. 
Especially S. pneumoniae, H. influenzae, and M. catarrhalis 
were susceptible in vitro to lemon balm (Melissa officinalis) 
oil, thyme (T. vulgaris) oil, cinnamon bark (Cinnamomum 
verum) oil, and lemon grass (Cymbopogon citratus) oil. The 
oils of peppermint (M. piperita) and eucalyptus (Eucalyptus 
globulus) frequently used for the treatment of colds displayed 
lower activity. Interestingly, in gaseous phase, concentrations 
of 1.56–6.25 µg/ml of the most active oils were sufficient to in-
hibit bacterial growth, so that an antibacterial effect on inhala-
tion might be plausible [27, 28].
Investigations on the antibacterial activity of essential oil 
components displayed similar results: most active groups of 
constituents were monoterpene alcohols and aldehydes as well 
as phenols and cinnamaldehyde with MIC-values of 160–300 
µg/ml to both S. pneumoniae and H. influenzae [27, 28, 32]. 
Tee Tree Oil Activity in Staphylococcus aureus Cells –  
an Electron Microscopic Study
Staphylococcus aureus is one of the most important Gram-
positive bacteria in humans, causing localized or generalized 
septic infections. Methicillin-resistant strains (MRSA) usually 
colonize the anterior nares of hospital patients and healthy in-
dividuals and cause epidemics in hospitals.
TTO is successfully used worldwide in nursing, in skin care 
cosmetics, and to treat certain local bacterial and fungal infec-
tions [33–35]. TTO could be shown to reveal a high antibacteri-
al activity against S. aureus in vitro and in vivo [36, 37]. To learn 
more about the mode of action, we studied the biological effect 
of TTO on cell ultrastructures, such as cytoplasm, cytoplasmic 
membrane, and cell wall using electron microscopy [38].
S. aureus belongs to the micrococcus family forming round 
to oval cells (fig. 1a) which are usually arranged in clusters. 
Untreated bacteria displayed normally dividing staphylococci 
cells (fig. 1b) and a sharp delineation between cell wall, cyto-
plasmic membrane, and the cytoplasm. In addition, cytoplasm 
revealed an evenly granular distribution. After 12 h expo-
sure to a subminimum inhibitory concentration (sub-MIC) of 
0.12% TTO, neither cell shape nor cell wall and cytoplasmic 
membrane revealed any irregularities or alterations. In con-
trast, cell division of the bacterial cells seemed to be inter-
rupted, and, in the cytoplasm, lamellar-like membrane rods 
were seen (fig. 1c). The formation of lamellar-like membrane 
Fig. 1.a Normal coccoidal S. aureus cell; cw = 
cell wall, b Dividing S. aureus cell with cross 
wall formation; cw = cell wall, c TTO(0.12%)-
treated S. aureus cell with a lamella-like mem-
brane (= mesosome), d TTO(0.25%)-treated 
S. aureus cell with condensed material (= cm).
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or so-called mesosome-like membrane structures seems to be 
an expression of general cell damage. This observation indi-
cates that there is a lasting effect of sub-MIC of 0.12% TTO 
on cell physiology.
These findings correspond very well to experiences with 
antibiotics. Ultrastructural changes in bacterial cells produced 
by antibiotics at MIC levels differ clearly from those obtained 
by antibiotics at sub-MIC [39]. After 12 h of incubation of the 
bacterial cells with the MIC of 0.25% TTO, dramatic cellular 
alterations became visible on electron microscopic image: Cell 
division was inhibited completely, in cytoplasm a clear segre-
gation of previously distributed cell components was found, 
Table 5. Cell targets and physiological effects of selected essential oils
Targets Bacteria/Fungi Substances References
Cell morphology
Forming elongated filamentous forms after treatment  
with essential oil; normal cells: 3–5 µm in length;  
elongated cells: 10–25 µm in length
E. coli palmarosa oil; peppermint oil [44]
Alteration of cell shape: cells of wild type exhibit  
a flask-shaped morphology, whereas TTO-treated  
strains form ovoid or round cells.
M. pneumoniae TTO [25]
Cytoplasmic membrane (alteration of integrity  
and permeability)
Inhibition of cell respiration E. coli; S. aureus; C. albicans TTO [35, 40, 41]
Inhibition of oxygen uptake, respiratory electron  
flow and oxidative phosphorylation
R. sphaeroides thymol, carvacrol and other monot-
erpene alcohols
[45]
K+ leakage E. coli; S. aureus TTO; farnesol, nerolidol [40, 41, 46, 47]
Depletion of intracellular ATP concentration E. coli, L. monocytogenes;  
E. coli
oregano oil, cinnamon oil,  
savory oil; carvacrol, thymol
[48, 49]
Formation of multilamellar, mesosome-like structures S. aureus TTO; terpinen-4-ol [38, 50]
Changes in membrane permeability Candida albicans, C. glabrata, 
Saccharomyces cerevisiae
TTO; terpinen-4-ol; α-terpineol; 
1.8-cineol; γ-terpinene;  
α-terpinene
[34]
Changes in membrane fluidity Candida albicans; C. glabrata;  
S. cerevisiae
TTO; 1.8-cineol;  
terpinen-4-ol; α-terpinene
[34]
Lesion of cytoplasmic membrane; reduction of  
ergosterol content in the cell membrane
C. albicans,  
Aspergillus fumigatus
Thymus pulegioides oil [18]
Cell wall
Formation of extracellular blebs E. coli TTO; lemongrass oil [51, 52]
Disintegration of outer membrane (OM) and  
OM-associated LPS release
E. coli thymol, carvacrol [48]
Cell lysis S. pneumoniae; E. coli,  
B. subtilis
oregano oil, thyme oil;  
oregano oil, clove oil
[33, 53]
Cell division
Total inhibition of cell division S. aureus TTO [38]
Anti-R-plasmid activity
Elimination of R-plasmids E. coli peppermint oil, rosemary oil,  
eucalyptus oil; menthol
[54]
Cell cytoplasm/cytosol
Formation of condensed, filamentous,  
electron-dense material in the cytoplasm/cytosol
S. aureus TTO [38]
Bacteria: Bacillus subtilis (B. subtilis), Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), Streptococcus pneumoniae (S. pneumoniae), Rho-
dopseudomonas sphaeroides (R. sphaeroides), Listeria monocytogenes (L. monocytogenes), Mycoplasma pneumoniae (M. pneumoniae). 
Fungi: Candida albicans (C. albicans). 
Essential oil: Palmarosa oil: Cymbopogon martini oil; peppermint oil: Mentha piperita oil; TTO: Melaleuca alternifolia oil; oregano oil: Origanum 
vulgare oil; cinnamon oil: Cinnamomum verum oil; savory oil: Satureja montana oil; lemon grass oil: Cymbopogon citratus oil; clove oil: Syzygium 
aromaticum oil; rosemary oil: Rosmarinus officinalis oil; eucalyptus oil: Eucalyptus globulus oil.
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new fibrous electron-dense structures were seen, and lamel-
lar-like membrane rods were no longer visible (fig. 1d). 
Interestingly, there was no shrinkage or busting of bacte-
rial cells in the MIC dose range; furthermore, neither the cell 
walls nor the cytoplasmic membranes seemed to be destroyed 
by TTO.
In a similar electron microscopic study, Escherichia coli 
cells cultivated in the presence of TTO (MIC: 0.25%) showed 
a loss of electron-dense material, coagulation of cell cytoplasm 
as well as the formation of extracellular blebs. In addition, 
Cox et al. [40, 41] could demonstrate that TTO concentrations 
that inhibit the growth of E. coli and S. aureus also inhibited 
cell respiration, stimulated the leakage of intracellular K+-
ions, and altered the permeability of the bacterial cytoplasmic 
membrane.
Mode of Antimicrobial Action
While essential oils were extensively tested against a broad 
spectrum of bacteria, yeasts, and fungi, the interaction be-
tween essential oils and microbes which ultimately induces the 
antimicrobial activity is not well understood. Hitherto, differ-
ent target sites and modes of action are discussed (table 5). 
Previously, Takaisi-Kikuni et al. [42] studied the effect of vari-
ous amounts of the essential oil of Cymbopogon densiflorus on 
the metabolic activity, growth, and morphology of S. aureus. 
Relatively high concentrations of the oil impaired staphylococ-
cal growth in a bacteriostatic manner (chloramphenicol-type), 
and in low doses metabolism became ineffective due to energy 
losses in the form of heat. Ultrastructural data revealed mor-
phological changes characteristic of the induction of bacterio-
lysis by bactericidal antibiotics (penicillin-type). Hammer et al. 
[34] investigated the antifungal effects of tea tree (M. alterni-
folia) oil and several of its components on Candida albicans, 
Candida glabrata, and Saccharomyces cerevisiae. TTO and 
its components were reported to alter both permeability and 
membrane fluidity of the yeasts tested. Based on these results, 
it was assumed that the essential oils may have antimicrobial 
activity by influencing bacterial and fungal targets involved in 
cytoplasmatic and cell wall metabolism. It is stated by several 
researchers that especially monoterpenes will increase cyto-
plasmic membrane fluidity and permeability, disturb the order 
of membrane embedded proteins, inhibit cell respiration, and 
alter ion transport processes [32, 43]. 
Essential Oils with Antiviral Properties
Natural products, either as pure compounds or as standard-
ized plant extracts, provide unlimited opportunities for new 
antiviral drugs, since the chemical diversity provides un-
matched availability [55]. Besides small molecules from me-
dicinal chemistry, natural products are still major sources of 
innovative therapeutic agents for various conditions, includ-
ing infectious diseases. Infectious viral diseases remain an im-
portant worldwide problem, since many viruses have resisted 
prophylaxis or therapy longer than other microorganisms. At 
the moment, only few effective antiviral drugs are available 
for the treatment of viral diseases. There is a need to find 
new substances with not only intracellular but also extracellu-
lar antiviral properties. The methods commonly used for the 
evaluation of in vitro antiviral activities of synthetic and natu-
ral substances are based mainly on the inhibition of cytopathic 
effects, the reduction or inhibition of plaque formation, and 
the reduction in the virus yield, but also on other viral func-
tions in selected host cell cultures.
Inhibition Activity against Different Human Viruses
There is considerable evidence emerging from in vitro studies 
and controlled trials of the potential of plant-derived phyto-
antiviral agents for the treatment of human viral infections. 
Many essential oils were investigated towards their antiviral 
activity. Most of them were tested against enveloped RNA 
and DNA viruses, such as herpes simplex virus type 1 and 
type 2 (DNA viruses), dengue virus type 2 (RNA virus), Junin 
virus (RNA virus), and influenza virus (RNA virus), whereas 
only few essential oils, e.g. oregano (Origanum vulgare) oil 
and clove (Syzygium aromaticum) oil, were also tested against 
non-enveloped RNA and DNA viruses, such as adenovirus 
type 3 (DNA virus), poliovirus (RNA virus), and coxsackie-
virus B1 (RNA virus).
Herpes simplex virus type 1 (HSV-1) causes some of the 
most common viral infections in humans, such as mucocuta-
neous herpes infections, herpetic keratitis, herpetic encepha-
litis, and neonatal herpes. Following primary infection, the 
particles of HSV-1 are carried by retrograde transport via 
sensory nerve endings to the ganglia, where the virions re-
main in a latent state until the development of reactivation 
by different stimuli. Acyclovir, a nucleoside analogue and 
selective anti-herpetic agent which has been widely used for 
therapy, inhibits the viral DNA replication through viral 
thymidine kinase, resulting in a potent inhibition of viral 
DNA synthesis. However, acyclovir-resistant herpesviruses 
have been increasingly isolated, particularly from immuno-
compromised hosts, such as patients with AIDS or malig-
nancy, and recipients of bone marrow or organ transplanta-
tion [56, 57]. 
The antiviral activity of the essential oils tested could 
be clearly demonstrated for enveloped DNA and RNA 
viruses (table 6). In contrast, the non-enveloped viruses 
were not affected by essential oils. A high antiviral effect 
of several essential oils against acyclovir-resistant clinical 
isolates of herpes simplex virus has been demonstrated re-
cently [58].
Mode and Mechanism of Antiviral Action
The best candidates as clinically useful antiviral drugs are 
substances which act on specific steps of viral biosynthesis. 
They inhibit specific processes in the viral replication cycle, 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
7/
7/
20
16
 8
:2
7:
50
 A
M
Forsch Komplementmed 2009;16:79–90Antimicrobial Properties of Essential Oils 85
so that little or no viral progeny is produced. These antiviral 
drugs should act at low concentrations and should not influ-
ence the host cell machinery, prevent the spread of viruses, 
and ultimately cure infected cells. On the other hand, viru-
cidal drugs denature viral structural proteins or glycopro-
teins, thus, infectivity of virus particles is completely lost. To 
learn more about the antiviral mechanism of essential oils on 
enveloped viruses, we investigated exemplarily the antiviral 
activity of anise (Pimpinella anisum) oil, hyssop (Hyssopus 
officinalis) oil, thyme (T. vulgaris) oil, dwarf-pine (Pinus 
mugo) oil, citrus (Citrus limon) oil, manuka (Leptospermum 
scoparium) oil, ginger (Zingiber officinale) oil, camomile 
(Matricaria recutita) oil, and sandalwood (Santalum album) 
oil against HSV-1 and HSV-2 in vitro. The replication cycle 
of herpes simplex virus is characterized by a complex se-
quence of different steps which offers opportunities to anti-
viral agents to intervene. In order to determine the mode of 
action, essential oils were added to host cells (African green 
monkey kidney cells) and viruses at different times during 
viral infection to identify the stage and target site at which 
infection might be inhibited, 
(i)  host cells (African green monkey kidney cells) were pre-
treated for 1 h with essential oils prior to inoculation with 
herpesviruses (pretreatment cells),
(ii)  herpesviruses were incubated with essential oils for 1 h 
prior to infection of host cells (pretreatment viruses),
(iii)  herpesviruses were mixed with essential oils and added to 
the host cells immediately (adsorption),
(iv)  host cells were incubated with essential oils after penetra-
tion of herpesviruses into the cells (intracellular replica-
tion).
Inhibition of HSV replication was measured by a plaque re-
duction assay as described previously [64]. In this assay, the 
number of plaques (pfu; plaque forming units) of drug-treated 
viruses were expressed in percent of the untreated control 
(number of plaques formed by viruses in the absence of essen-
tial oil). In all assays the maximum noncytotoxic concentra-
tions of the essential oils tested were used.
Origin of essential oil Virus IC50, %; ppm References
Aloysia gratissima HSV-1 65 ppm [59]
Artemisia arborescens HSV-1/HSV-2 2.4/4.1 μg/ml [60]
Artemisia douglasiana HSV-1 83 ppm [59]
Cinnamonum verum HSV-1 0.008% [61]
Citrus limon HSV-1 0.0015% [62]
Cymbopogon citratus HSV-1 0.1% [63]
Eucalyptus globulus HSV-1/HSV-2 0.009/0.008% [64]
Eupatorium patens HSV-1 125 ppm [59]
Hyssopus officinalis HSV-1/HSV-2 0.0001/0.0006% [62, 65]
Illicium verum HSV-1/HSV-2 0.004/0.003% [62, 66]
Juniperus oxycedrus HSV-1 0.02% [67]
Lavandula latifolia HSV-1 1% [63]
Leptospermum scoparium HSV-1/HSV-2 0.0001/0.00006% [68]
Matricaria recutita HSV-1/HSV-2 0.00003/0.00015% [62, 66]
Melaleuca alternifolia HSV-1/HSV-2 0.0009/0.0008% [64]
Mentha piperita HSV-1/HSV-2 0.002/0.0008% [69]
Origanum majorana HSV-1 1% [63]
Pinus mugo HSV-1/HSV-2 0.0007% [62, 66]
Rosmarinus officinalis HSV-1 1% [63]
Santalum album HSV-1/HSV-2 0.0002/0.0005% [62, 65]
Santolina insularis HSV-1/HSV-2 0.0001% [70]
Tessaria absinthioides HSV-1 105 ppm [59]
Thymus vulgaris HSV-1/HSV-2 0.001/0.0007% [62, 65]
Zingiber officinale HSV-1/HSV-2 0.0002/0.0001% [62, 65]
Artemisia douglasiana DEN-2 60 ppm [59]
Eupatorium patens DEN-2 150 ppm [59]
Origanum vulgare NDV 0.025% [71]
Laurus nobilis SARS-CoV 0.012% [67]
Lippia junelliana Junin virus 20 ppm [59]
Lippia turbinata Junin virus 14 ppm [59]
IC50 = 50% inhibitory concentration; HSV = herpes simplex virus (DNA virus); DEN = dengue 
virus (RNA virus); NDV = Newcastle disease virus (DNA virus); SARS = severe acute respiratory 
syndrome; SARS-CoV = SARS-associated coronarvirus (RNA virus); Junin virus (RNA virus).
Table 6. Antiviral activity of essential oils 
against different human viruses
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According to our findings, pretreatment of cells with essen-
tial oils for 1 h prior to virus infection did not reduce the virus 
plaque formation, indicating that essential oils did not affect 
the adsorption of viruses to cell surface, and did not interfere 
with virus binding by blocking cellular receptors. On the other 
hand, pretreatment of viruses with essential oils for 1 h prior 
to cell infection caused a significant reduction of plaques of 
95–99% for HSV-1 and of 70–98% for HSV-2, respectively 
(fig. 2). Out of the oils tested, only dwarf-pine (P. mugo) oil 
and citrus (C. limon) oil reduced plaque formation of about 
80% for HSV-1 and HSV-2 when added during adsorption of 
virus to host cells [62, 65, 68].
In contrast, when essential oils were added to the overlay 
medium after penetration of viruses into the host cells, only 
manuka (L. scoparium) oil significantly reduced plaque for-
mation of HSV-1 of about 40%. Only few reports demonstrat-
ed a virucidal activity of essential oils against herpesviruses. 
Saddi et al. [60] recently demonstrated the virucidal effect of 
Artemisia arborescens essential oil against HSV-1 and HSV-2. 
In conclusion, our results indicate that in particular free 
viruses are very sensitive to essential oils. Both types of her-
pes simplex virus are affected before adsorption or during 
adsorption to cell surface but not after penetration into cells, 
the typical mode of action of nucleoside analogues like acy-
clovir. These findings suggest that essential oils interfere with 
the virus envelope or by masking viral components which are 
necessary for adsorption or entry into host cells. An electron 
microscopic examination demonstrated that the envelope of 
HSV-1 was disrupted when treated with oregano (O. vulgare) 
oil and clove (S. aromaticum) oil [71]. Furthermore, eugenol 
(4-hydroxy-3-methoxy-allyl-benzene), the main component 
of clove oil, was shown to be a very effective agent against 
HSV-1 and HSV-2 in vitro [72]. All these findings are in ac-
cordance with the data of investigations on the antiviral activ-
ity of essential oils against enveloped DNA and RNA viruses 
mentioned above.
Clinical Trials
A randomized, placebo-controlled, investigator-blinded proto-
col was used to evaluate the efficacy of tea tree essential oil 
(6% TTO gel) in the treatment of recurrent herpes labialis [73]. 
The median time to re-epithelization after treatment with this 
essential oil was 9 days compared to 12.5 days after placebo, in-
dicating some benefit from essential oil treatment. TTO might 
be a potentially useful, cheaper alternative for other topical 
therapies, which poses little threat of inducing resistance to an-
tiviral agents. Besides essential oils, many other herbal prepa-
rations with antiviral activity were identified, clinical trials have 
been performed, and most of them described benefits for the 
treated patients [74]. There remains a need for larger, strin-
gently designed, randomized clinical trials with essential oils to 
provide conclusive evidence of their efficacy.
Summary
In summary, there is considerable evidence emerging from 
in vitro studies and controlled clinical trials of the potential 
of plant-derived substances as leads for the development of 
antiviral drugs against viral infections. In particular, the an-
tiviral properties of essential oils from several plant extracts, 
responsible for their characteristic odor, have been described 
in recent years. Various viruses, including the human patho-
gen herpes simplex virus, were found to be very susceptible 
to the inhibitory action of essential oils. These results support 
the potential use of essential oils in toto from medicinal plants 
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Fig. 2. Effect of different essential oils on 
herpes simplex virus type 1 and type 2 infec-
tivity after pretreatment of viruses for 1 h 
with maximum noncytotoxic concentrations 
of essential oils. Untreated controls were ar-
bitrarily set to 100%. Data represent remain-
ing decreased viral infectivity compared to 
untreated herpesvirus. PFU = Plaque forming 
unit. Anis oil: Pimpinella anisum oil; hyssop 
oil: Hyssopus officinalis oil; thyme oil: Thymus 
vulgaris oil; dwarf pine oil: Pinus mugo oil; 
citrus oil: Citrus limon oil; manuka oil: Lepto-
spermum scoparium oil; ginger oil: Zingiber 
officinale oil; camomile oil: Matricaria recutita 
oil; sandalwood oil: Santalum album oil.
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Table 7. Cytotoxicity of essential oils in vitro
Origin of essential oil Cell line Incubation time, h CC50, µg/ml References
Backhousia citriodora  
(lemon myrtle)
F1–73
dermal epithelial cells
 4
24
 140
 100
[75]
dermal fibroblasts  4
24
 120
  70
HepG2 (liver carcinoma)  4
24
  80
  40
Commiphora molmol  
(myrrh)
gingival fibroblasts 24
48
 ≥25
   5–10 
[76]
gingival epithelial cells 24
48
 ≥25
   5–10 
Lavandula angustifolia  
(lavender)
HMEC-1 (microvascular endothelial cells)  1 1950 [77]
HNDF 
(dermal fibroblasts)  1 1840
153BR (fibroblasts)  1 1690
Lavandula stoechas KB (epidermoid carcinoma)  n.a.  >20 [78]
KB-V (drug resistant KB)  >20
BC-1 (mamma carcinoma)  >20
Lu-1 (lung carcinoma)  >20
Col-2 (colon carcinoma)    9.8
LNCaP (prostate carcinoma)   17.6
P388 (murine leukemia)   >5
3T6 (fibroblasts)  286.8
Syzygium aromaticum 
(clove)
HMEC-1 (see above)  1  180 [79]
HNDF  1  250
153BR  1  170
Melissa officinalis  
(lemon balm)
HEp-2 (epidermoid carcinoma) 48  >100 [80]
Melissa officinalis A549 (lung carcinoma) 48   20–100 [81]
Caco-2 (colon carcinoma)
MCF-7 (mamma carcinoma)
HL-60 (leukemia)
K562 (leukemia)
B16F10 (murine)
Melissa officinalis HaCaT (keratinocytes) 48   15.3 [30]
BEAS-2B (bronchial epithelial cells) 48   10.6
Nepeta cataria  
(catnip)
HaCaT (keratinocytes) 48  165.7
BEAS-2B (bronchial epithelial cells) 48  161
Santalum album RC-37 (monkey kidney) 96   15 [62]
Matricaria recutita   30
Leptospermum scoparium   35
Pinus mugo   40
Zingiber officinale   40
Citrus limon   45
Melaleuca alternifolia RC-37 96   60 [64]
Thymus vulgaris RC-37 96   70 [62]
Hyssopus officinalis   75
Mentha piperita RC-37 96  140 [69]
Illicium verum RC-37 96  160 [62]
Eucalyptus globulus RC-37 96  300 [64]
CC = Cytotoxic concentration; CC50 = effective concentration of the test compound which kills 50% of the cells tested; n.a. = not applicable.
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as agents for the treatment of viral infections and suggests the 
application of this type of natural products as disinfectants or 
topical antiviral drugs. 
Cytotoxicity and Its Consequences on the 
 Antibacterial and Antiviral Properties of Essential Oils
Cytotoxicity of Essential Oils in vitro
The pharmaceutical market offers a wide range of drug prod-
ucts for topical application that contain essential oils. The use 
of essential oils as antimicrobial agents is not only limited by 
their effective concentrations in vitro but also by the concen-
trations that can be obtained at the site of action. These de-
pend on the one hand on resorption and transport of the ac-
tive constituents but on the other hand on the maximum dos-
age that can be administered without toxic side effects. 
Regarding essential oils a number of investigations in cell cul-
ture systems have been carried out in order to predict their 
toxicity to mammalian cells in vivo (table 7). Most of the in 
vitro tests were carried out using human fibroblasts or dermal 
epithelial cells, but also tumor cell lines were used. Others use 
monkey kidney cells as they are also suitable for antiviral tests.
Essential oils exert cytotoxic activity in vitro at CC50 values 
from 5.0–1,950 µg/ml depending on incubation time (1–96 
h). In comparison, to achieve an antibacterial effect in vitro, 
essential oil concentrations of about 20–20,000 µg/ml are re-
quired. That means that essential oils may exert cytotoxic ef-
fects to tissue cells at concentrations which do not yet show an 
antibacterial effect. On the other hand, essential oils exhibit 
antiviral activity even at IC50 values of 1–200 µg/ml.
The cytotoxic activity of essential oils is based on their indi-
vidual components. As in bacterial cells, the cell membrane is 
one of the sites of action where essential oils and essential oil 
components were shown to cause permeabilization and depo-
larisation and to reduce the activity of membrane-associated 
enzymes [82]. In addition, an interaction with cellular metabo-
lism [82, 83] and an induction of apoptosis have been demon-
strated for essential oils and oil components [84–86].
Implications for Therapeutic Use of Essential Oils
In vitro cytotoxicity data may overestimate the toxicity of a 
substance in vivo, as neither tissue structures nor biotrans-
formation and transport processes may be simulated in cell 
culture. Most cell culture models use a cell monolayer which 
is brought in direct contact with the test substance in culture 
medium and incubated for up to 96 h – these test conditions 
display the ‘worst case’, which is unlikely to occur in vivo. 
Correlations of in vitro and in vivo toxicity data have been 
carried out in order to develop models that allow a prediction 
of systemic toxicity in vivo from cell culture data. One exam-
ple is the system of Halle and Göres [87] (table 8).
According to this classification, the expected systemic toxicity 
of most essential oils can be rated as moderate to low. Clinical 
studies about the topical use of essential oils (e.g. TTO, euca-
lyptus oil, and pine (Pinus sylvestris) needle oil) demonstrate 
that they are tolerated well both when used inhalatively or 
when applied to the skin in topical formulation. Adverse ef-
fects that were reported are local irritation on skin and mucous 
membranes as well as allergic reactions including contact der-
matitis [35–37, 88, 89]. However, the ingestion of a few millilit-
ers of essential oils may cause severe symptoms of intoxication 
like vomiting, respirational failure, and unconsciousness and 
may lead to death especially when infants are concerned [89].
From in vitro cytotoxicity data and the reports about toxic-
ity and irritation potential in vivo, it is recommended strictly 
not to exceed the maximum daily dosage, when administered 
orally. In addition, the undiluted oils or preparations with high 
concentrations of essential oils should not be applied to mu-
cous membranes or damaged skin. For inhalational use, the 
oils should be dosed in a way that they are barely detectable 
by odor as for many oils these concentrations were shown to 
facilitate secretolysis in an animal model most effectively in 
comparison to higher doses [90]. In addition, it was shown on 
ciliated nasal epithelium that low concentration of essential 
oil (0.2%) stimulated the ciliary beat frequency more effec-
tively than high concentrations (2%) [91]. This is in accord-
ance to the findings of Riechelmann and co-workers [92], who 
reported a decrease of ciliary beat frequency in human ciliated 
Classification CC50, mmol/l CC50, µg/ml;  
for MW = 200
LD50 (oral, rat/mouse), 
mg/kg
1 Highest level of toxicity <0.0001 <0.02 >5
2 Extremely toxic 0.0001−0.001 0.02−0.2 5−50
3 Highly toxic 0.001−0.01 0.2−2.0 50−500
4 Moderately toxic 0.01−0.1 2.0−20 500–5000
5 Little toxic 0.1−1.0 20−200 5000−15000
6 Very little toxic 1.0−10 200−2000 >15000
7 Non-toxic >10 >2000 –
CC50 = Effective concentration of the test compound which kills 50% of the cell lines; LD50 = 
lethal dose; LD50 is the amount of a compound/material which causes the death of 50% of test 
animals; MW = molecular weight.
Table 8. In vitro classification of cytotoxicity 
and prediction of in vivo toxicity of substances 
according to Halle and Göres [87]
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